Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Assessment of Aminoglycoside-Induced Hearing Loss Risk in the Perinatal Period
Thompson, Whitney S. , Saba, Leslie , Hasadsri, Linda , Girard, Sylvie, Schimmenti, Lisa A. , Bendel‐Stenzel, Ellen , Wick, Myra , Brumbaugh, Jane E. , Schimmenti, Lisa A , Brumbaugh, Jane E , Thompson, Whitney S

American Journal of Perinatology | July 15, 2024 | Volume: 42 | Issue: 01 | Pages: 126-129

10.1055/s-0044-1788335 | PMID 39008985 Get It

Objective This study aimed to determine the prevalence and heteroplasmy level(s) of MT-RNR1 variants m.1555A > G and m.1494C > T, which are associated with aminoglycoside-induced hearing loss, in a general perinatal population. This study also aimed to characterize the association of these variants and their heteroplasmy levels with hearing loss outcomes with and without aminoglycoside exposure. Study Design Droplet digital polymerase chain reaction was performed on 479 maternal DNA samples from a general perinatal biobank at our institution to detect the presence and heteroplasmy levels of MT-RNR1 variants m.1555A > G and m.1494C > T. Testing of paired neonatal specimen(s) was planned for positive maternal tests. A retrospective chart review was performed to characterize the population, identify aminoglycoside exposures, and determine hearing outcomes. Results All maternal samples tested negative for MT-RNR1 variants m.1555A > G and m.1494C > T. Maternal and neonatal subjects had high rates of aminoglycoside exposure (15.9 and 13.9%, respectively). No subjects with sensorineural or mixed hearing loss had documented aminoglycoside exposure. Conclusion This study demonstrated that a larger sample size is needed to establish the prevalence of these variants as no subjects tested positive. Determination of variant prevalence in the neonatal population, association of variant heteroplasmy levels with hearing outcomes, and reliability of maternal testing as a surrogate for neonatal testing are important next steps toward universal prenatal or newborn screening. Key Points
Local Cutaneous Scrotal Involvement of Paratesticular Mesothelioma
Maniam, Ganesh , Gupta, Sounak , Agrawal, Shruti , Tekin, Burak , Nguyen, Giang

The American Journal of Dermatopathology | July 15, 2024 | Volume: 46 | Issue: 10 | Pages: e91-e95

10.1097/dad.0000000000002802 | PMID 39008503 Get It

Abstract: Paratesticular mesothelioma (malignant mesothelioma arising from the tunica vaginalis of the testis) represents a small proportion of mesothelial neoplasms, and cutaneous involvement by paratesticular mesothelioma is very rare. Cutaneous involvement can manifest as scrotal subcutaneous nodules from regional spread, distant metastasis, or direct extension through surgical scars. Mesothelioma has 3 histopathologic classifications that include epithelioid, biphasic, and sarcomatoid, which is rarely seen in paratesticular mesothelioma. Given the rarity of this condition, cutaneous mesothelioma may be misdiagnosed as histologic mimics, such as metastatic adenocarcinoma or adnexal neoplasms; thus, appropriate immunohistochemical workup and clinical correlation are required to make an accurate diagnosis. In this case, a 75-year-old man with a history of paratesticular mesothelioma, status postorchiectomy, presented with right-sided scrotal swelling, erythema, and subcutaneous nodules. These nodules were identified as local recurrence with cutaneous involvement by paratesticular mesothelioma on histopathologic examination. This case highlights the clinical and histopathologic features of this diagnosis and underscores the importance of dermatopathologists being aware of this condition to ensure accurate diagnosis.
Plasma Transfusion and Recipient Outcomes: One Size Does Not Fit All!
Kor, Daryl J. , Görlinger, Klaus , Shander, Aryeh

Anesthesia & Analgesia | July 15, 2024 | Volume: 139 | Issue: 2 | Pages: 251-253

10.1213/ane.0000000000006963 | PMID 39008863 Get It

Autoimmune ‘secondary synaptopathies’: do NMDAR antibodies cause a primary extra-synaptopathy?
Zhao, Meng , Irani, Sarosh R. , Irani, Sarosh R , Zhao, Meng , Lynch, David R.

Brain | July 15, 2024 | Volume: 147 | Issue: 8 | Pages: 2601-2603

10.1093/brain/awae236 | PMID 39073761 Get It

This scientific commentary refers to ‘NMDA receptor autoantibodies primarily impair the extrasynaptic compartment’ by Jamet et al. (https://doi.org/10.1093/brain/awae163).
Dosimetric consequences of flap dose due to rapid beam off control for a high intensity carbon ion radiation therapy synchrotron
Tsubouchi, Toshiro , Nomura, Takuya , Kanai, Tatsuaki, Beltran, Chris , Beltran, Chris J , Furutani, Keith M. , Yagi, Masashi , Shimizu, Shinichi

Medical Physics | July 15, 2024 | Volume: 51 | Issue: 10 | Pages: 7393-7403

10.1002/mp.17309 | PMID 39008830 Get It

AbstractBackgroundIn carbon ion radiation therapy (CIRT) the predominant method of irradiation is raster scanning, called dose driven continuous scanning (DDCS) by Hitachi, allowing for continuous synchrotron extraction. The reduction in irradiation time is highly beneficial in minimizing the impact of patient and target movement on dose distribution. The RF knock out (RFKO) slow‐extraction method is commonly used for beam on/off control. When the Hitachi synchrotron receives a beam off signal the control system stops the RFKO and after some delay time (t‐delay) during which the beam intensity declines, a high‐speed steering magnet (HSST) is used to sweep the remaining beam from isocenter to a beam dump for safety reasons. Mayo Clinic Florida (MCF) will use a very short delay of the HSST operation from the RFKO beam OFF signal to minimize the delay time and delayed dose. MCF clinical beam intensity, a tenfold increase over HIMAK, is still less than 100 mMU/ms (approximately 4.9 × 109 pps for 430 MeV/u).PurposeThe rapid beam off control (RBOC) proposed for MCF is associated with the occurrence of flap dose (FD), which refers to the asymmetric shoulder of the spot dose profile formed from the beam bent by HSST deviating from its planned spot position on the isocenter plane. In this study, we quantitatively assessed FD, proposed a treatment planning system (TPS) implementation using a flap spot (FS) and evaluated its impact on dose distribution.MethodThe experiments were conducted at the Osaka Heavy Ion Therapy Center (HIMAK) varying the t‐delay from 0.01 to 1 ms in a research environment to simulate the MCF RBOC. We studied the dependence of FD position on beam transport and its dependence on energy and beam intensity. FD was generated by delivering 10000 continuous spots on the central axis that are occasionally triggered by an external 10 Hz gate signal. Measurements were conducted using an oscilloscope, and the nozzle's spot position monitor (SPM) and dose monitor (DM).ResultAll spot profile data were corrected for the gain of the SPM's beam intensity dependence. FD was determined by fitting the (SPM) Profile data to a double Gaussian. The position of the FS was found to be transport path dependent, with FS occurring on the opposite sides of the scanning x‐direction for vertical and horizontal ports, respectively, as predicted by transport calculations. It was observed that the FD increases with beam intensity and did not exhibit a significant dependence on energy. The effect of FD on treatment planning is shown to have no significant dose impact on the organs at risk (OARs) near the target for clinical beam intensities and a modest increase for very high intensities.ConclusionUsing HIMAK in research mode the implications are that the FD has no clinical impact on the clinical CIRT beam intensities for MCF and maybe planned for higher intensities by incorporating FS into the TPS to predict the modest increased dose to OARs. A method for commissioning and quality assurance of FD has been proposed.
Specification and de-labelling of unspecified allergic reactions to penicillins at a family medicine clinic
Ton, Angie , Ilges, Dan , Ton, Angie Nu , Ilges, Dan

BMJ Open Quality | July 15, 2024 | Volume: 13 | Issue: 3 | Pages: e002785

10.1136/bmjoq-2024-002785 | PMID 39009463 Get It

Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility
Adedinsewo, Demilade , Adedinsewo, Demilade A

Circulation | July 15, 2024 | Volume: 150 | Issue: 3 | Pages: 174-176

10.1161/circulationaha.124.068113 | PMID 39008553 Get It

Acute Respiratory Distress Syndrome and the Meaning of Hospital Mortality*
Qadir, Nida , Bauer, Philippe R.

Critical Care Medicine | July 15, 2024 | Volume: 52 | Issue: 8 | Pages: 1319-1321

10.1097/ccm.0000000000006340 | PMID 39007577 Get It

Genetic diversity accelerates canine distemper virus adaptation to ferrets
Siering, Oliver, Langbein, Mareike, Herrmann, Maike , Wittwer, Kevin , Messling, Veronika von , Sawatsky, Bevan , Pfaller, Christian K. , von Messling, Veronika , Pfaller, Christian K

Journal of Virology | July 15, 2024 | Volume: 98 | Issue: 8 | Pages: No page available

10.1128/jvi.00657-24 | PMID 39007615 Get It

ABSTRACT RNA viruses adapt rapidly to new host environments by generating highly diverse genome sets, so-called “quasispecies.” Minor genetic variants promote their rapid adaptation, allowing for the emergence of drug-resistance or immune-escape mutants. Understanding these adaptation processes is highly relevant to assessing the risk of cross-species transmission and the safety and efficacy of vaccines and antivirals. We hypothesized that genetic memory within a viral genome population facilitates rapid adaptation. To test this, we investigated the adaptation of the Morbillivirus canine distemper virus to ferrets and compared an attenuated, Vero cell-adapted virus isolate with its recombinant derivative over consecutive ferret passages. Although both viruses adapted to the new host, the reduced initial genetic diversity of the recombinant virus resulted in delayed disease onset. The non-recombinant virus gradually increased the frequencies of beneficial mutations already present at very low frequencies in the input virus. In contrast, the recombinant virus first evolved de novo mutations to compensate for the initial fitness impairments. Importantly, while both viruses evolved different sets of mutations, most mutations found in the adapted non-recombinant virus were identical to those found in a previous ferret adaptation experiment with the same isolate, indicating that mutations present at low frequency in the original virus stock serve as genetic memory. An arginine residue at position 519 in the carboxy terminus of the nucleoprotein shared by all adapted viruses was found to contribute to pathogenesis in ferrets. Our work illustrates the importance of genetic diversity for adaptation to new environments and identifies regions with functional relevance. IMPORTANCE When viruses encounter a new host, they can rapidly adapt to this host and cause disease. How these adaptation processes occur remains understudied. Morbilliviruses have high clinical and veterinary relevance and are attractive model systems to study these adaptation processes. The canine distemper virus is of particular interest, as it exhibits a broader host range than other morbilliviruses and frequently crosses species barriers. Here, we compared the adaptation of an attenuated virus and its recombinant derivative to that of ferrets. Pre-existing mutations present at low frequency allowed faster adaptation of the non-recombinant virus compared to the recombinant virus. We identified a common point mutation in the nucleoprotein that affected the pathogenesis of both viruses. Our study shows that genetic memory facilitates environmental adaptation and that erasing this genetic memory by genetic engineering results in delayed and different adaptation to new environments, providing an important safety aspect for the generation of live-attenuated vaccines.
Implementation of sentinel node biopsy in high-risk endometrial cancer
Occhiali, Tommaso , Vizzielli, Giuseppe , Vizzielli, Giuseppe , Mariani, Andrea

Current Opinion in Oncology | July 15, 2024 | Volume: 36 | Issue: 5 | Pages: 391-396

10.1097/cco.0000000000001060 | PMID 39007335 Get It

Purpose of review Endometrial cancer is the most common gynecologic malignancy and sentinel lymphnode biopsy is accepted as a valid alternative to lymphadenectomy for staging purposes. Recently, sentinel node biopsy has been also extended to high-risk disease where risk of nodal involvement is higher. Recent findings Our review focuses on the definition of high-risk disease and how there are different concepts of high-risk in the scientific community. While the sensitivity of sentinel node biopsy has been established and accepted in lower risk endometrial cancers, only in recent years retrospective and prospective evidence has been published. Ultrastaging allows to identify more nodal disease that would normally be overlooked by traditional staging, allowing proper adjuvant therapy to be administered. The longstanding question of whether lymphadenectomy in high-risk settings is a therapeutic or a staging procedure remains open. Retrospective data, however, show that oncologic outcomes are not compromised by sentinel node biopsy. Summary Sentinel node biopsy is a valid alternative to traditional, more extensive nodal staging: with the addition of ultrastaging, it has more sensitivity than lymphadenectomy with less surgical morbidity. Ongoing trials will definitively establish if oncological outcomes are affected by sentinel node biopsy, but retrospective data are encouraging.